Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II open-label study of NHWD-870 HCl in advanced NUT carcinoma in adults and adolescents
CTR20241375Phase 2Active
- Sponsor
- Zhejiang Wenda Pharmaceutical Technology Co., Ltd.
- Start
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of NHWD-870 in NUT carcinoma (NC), sponsored by Zhejiang Wenda Pharmaceutical Technology Co., Ltd.. Started Apr 2024; status: active.
02
Drugs
NHWD-870
03
Conditions
NUT carcinoma (NC)
Beyond the preview
Go deeper on CTR20241375.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20241375.